Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2026-09-02 18:01:55 ET · period of report 2026-09-01 · accession 0001601830-26-000103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-02 18:01 | 2026-09-01 | RXRX | Borgeson Blake | Dir | S - Sale | $3.34 | -30.0K | 6.16M | -0.5% | -$100.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-01 | S | D | 30,000 | $3.34 | 6,158,287 | D | — | — | (F1) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025. |